Haemophilia: open trials in Norway

• NCT07088458

  An Observational Study to Learn More About How Well Damoctocog Alfa Pegol Works in Previously Treated Children With Hemophilia A

  Research · Bayer

  Many Locations, Many Locations

  Registry updated 2026-10-26

• NCT04023019

  Treatment of Hemophilia A Patients With FVIII Inhibitors

  Research · Phase 4 · Emory University

  Oslo University Hospital HF, Oslo

  Registry updated 2026-09-23

• NCT03745924

  A Study Following Males With Haemophilia B on Prophylaxis With Refixia/REBINYN

  Research · Novo Nordisk A/S

  Klinisk forskningspost, Oslo

  Registry updated 2026-06-12

• NCT02979119

  The European Paediatric Network for Haemophilia Management ( PedNet Registry)

  Research · PedNet Haemophilia Research Foundation

  Oslo University Hospital, Oslo

  Registry updated 2025-09-16

• 2022-502030-12-01

  This is a first in human study, in patients with severe bleeding disorder (hemophilia A), who has developed inhibitory antibodies against coagulation factor VIII.The aim is to study the safety and efficacy of dendritic cells, originating from the patient itself. The dendritic cells has been loaded with coagulation factor VIII for an improved immunological tolerance. (TOLER8)

  Trial Treatment · Phase 1 · Cell4Cure AB

  Oslo University Hospital HF, Oslo

  Registry updated 2025-03-24

All Haemophilia trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error